Search alternatives:
small decrease » small increased (Expand Search)
point decrease » point increase (Expand Search)
Showing 1 - 20 results of 4,118 for search '(( significant burden decrease ) OR ( significant ((small decrease) OR (point decrease)) ))', query time: 0.54s Refine Results
  1. 1
    Decreased clonogenic capacity of U87MG and U251MG glioma cells dependent on SHG-44 concentration.

    Decreased clonogenic capacity of U87MG and U251MG glioma cells dependent on SHG-44 concentration. by Denis Mustafov (19137870)

    Published 2025
    Save to List
    Saved in:
  2. 2
    Decreased clonogenic capacity of U87MG and U251MG GB cells following treatment with SHG-44 and cis-platin at equal concentrations.

    Decreased clonogenic capacity of U87MG and U251MG GB cells following treatment with SHG-44 and cis-platin at equal concentrations. by Denis Mustafov (19137870)

    Published 2025
    Save to List
    Saved in:
  3. 3
    Patient demographic information at four time points.

    Patient demographic information at four time points. by Ruitian Song (11045127)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 4
    Innovation and night light in large and small cities.

    Innovation and night light in large and small cities. by Saul Estrin (8629173)

    Published 2024
    Save to List
    Saved in:
  5. 5
    Primary and secondary efficacy end points (intention-to-treat population).

    Primary and secondary efficacy end points (intention-to-treat population). by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 6
    Frontier analysis of injuries’ burden caused by fire, heat, and hot substances from 1990 to 2021.

    Frontier analysis of injuries’ burden caused by fire, heat, and hot substances from 1990 to 2021. by Shi Huang (125861)

    Published 2025
    Save to List
    Saved in:
  7. 7
    Scaling of overall health burden with yearly expenditure growth.

    Scaling of overall health burden with yearly expenditure growth. by Margherita Molaro (17803989)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 8
    nsP4-C483Y or Q192L mutations decrease sensitivity to 4′-FlU.

    nsP4-C483Y or Q192L mutations decrease sensitivity to 4′-FlU. by Peiqi Yin (6533747)

    Published 2025
    Save to List
    Saved in:
  9. 9
    Significantly Enriched Pathways.

    Significantly Enriched Pathways. by Jiyong Zhang (2498740)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 10
    Join-point regression analysis of the statistically significant linear increase in use of antidepressants during the observed time period.

    Join-point regression analysis of the statistically significant linear increase in use of antidepressants during the observed time period. by Jelena Filimonovic (22305307)

    Published 2025
    Save to List
    Saved in:
  11. 11
    Transepithelial resistance of NHBE decreases significantly after PAA exposure.

    Transepithelial resistance of NHBE decreases significantly after PAA exposure. by Ellie S. Burns (21246537)

    Published 2025
    Save to List
    Saved in:
  12. 12
    Sampling point (Source:

    Sampling point (Source: by Yonggang Huang (223155)

    Published 2025
    Save to List
    Saved in:
  13. 13
    ASDR of Tuberculosis for the 21 Global Burden of Disease regions by SDI, 1990-2021.

    ASDR of Tuberculosis for the 21 Global Burden of Disease regions by SDI, 1990-2021. by Xue Li (285380)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 14
    ASMR of Tuberculosis for the 21 Global Burden of Disease regions by SDI, 1990-2021.

    ASMR of Tuberculosis for the 21 Global Burden of Disease regions by SDI, 1990-2021. by Xue Li (285380)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 15
    Comparison of all–age cases with age–standardized incidence, prevalence,deaths, and DALYs in global men and women, 1990–2021.

    Comparison of all–age cases with age–standardized incidence, prevalence,deaths, and DALYs in global men and women, 1990–2021. by Zhengpeng Li (2322058)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 16
    Comparison of the number of incidence, prevalence, deaths and DALYs counts by age group and their crude ratios in China in 1990 and 2021.

    Comparison of the number of incidence, prevalence, deaths and DALYs counts by age group and their crude ratios in China in 1990 and 2021. by Zhengpeng Li (2322058)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 17
    Comparison of ASIR, ASPR, ASMR and ASDR trends in China and global RA from 1990 to 2021.

    Comparison of ASIR, ASPR, ASMR and ASDR trends in China and global RA from 1990 to 2021. by Zhengpeng Li (2322058)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 18
    Global comparison of incidence, prevalence, deaths and DALYs counts by age group and their crude rates, 1990 and 2021.

    Global comparison of incidence, prevalence, deaths and DALYs counts by age group and their crude rates, 1990 and 2021. by Zhengpeng Li (2322058)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 19
    Comparison of all–age cases with age–standardized incidence, prevalence,deaths, and DALYs in Chinese men and women, 1990–2021.

    Comparison of all–age cases with age–standardized incidence, prevalence,deaths, and DALYs in Chinese men and women, 1990–2021. by Zhengpeng Li (2322058)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 20
    Comparison of RA incidence, prevalence, death and DALYs among men and women of different age groups in China in 2021.

    Comparison of RA incidence, prevalence, death and DALYs among men and women of different age groups in China in 2021. by Zhengpeng Li (2322058)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: